Medical Excellence Capital
medexcelcap.com Direct investor
Medical Excellence Capital is an early-stage life sciences venture fund that invests in company creation, seed, Series A and Series B opportunities. It combines a network of physician-scientists with investment professionals and operators.
Medical Excellence Capital is a venture capital firm, founded in 2020. It invests directly in companies, from seed to Series B, in gene therapy, cell therapy, synthetic biology and regenerative medicine.
“MEC invests in company creation, seed, Series A, and Series B opportunities where technology and novel approaches are transformative for patient care and directly address large, unmet needs.”
— Medical Excellence Capital, own website
- Layer
- Direct investor
- Type
- Venture capital
- Sectors
- gene therapy, cell therapy, synthetic biology, regenerative medicine, AI/ML applied to drug discovery, precision medicine
- Founded
- 2020
Team, as Medical Excellence Capital publishes it
- John Prufeta Founder, CEO & Managing Partner
- Eric Heil, MBA Managing Partner
- Kim Kamdar, PhD Managing Partner
- Brian Halak, PhD Senior Advisor
- Joni Mancini, CPA Managing Partner
- Max Colbert MD, MBA Senior Associate
- Olga Prufeta MEC LP Liaison; Medical Excellence Group
Names and roles exactly as listed on medexcelcap.com. Nothing else about these people is recorded.
Where this comes from
Every fact above was read from a page Medical Excellence Capital publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://medexcelcap.com/name, stage_min, stage_max, thesis_quote
- https://medexcelcap.com/approach/is_investor, layer, type, sectors, description
- https://medexcelcap.com/team/founded, people
- https://medexcelcap.com/portfolio/status
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 16055 · added 2026-10-21 · link last verified 2026-10-21 · confidence high
Similar investors
- Civilization VenturesVenture capital · Pre-seed – Series A · United States
- Cancer Focus FundVenture capital · Houston, United States
- Westlake Village BioPartnersVenture capital · Los Angeles, United States
- Amplitude Venture CapitalVenture capital · Montreal, Canada
- Atlas VentureVenture capital · Seed – Series A · Cambridge, United States
- Dynamk CapitalVenture capital · New York, United States